Barclays’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
180,673
+68,362
| +61% | +$436K | ﹤0.01% | 2569 |
|
|
2025
Q1 | $545K | Buy |
112,311
+17,788
| +19% | +$86.3K | ﹤0.01% | 2793 |
|
|
2024
Q4 | $904K | Buy |
94,523
+55,215
| +140% | +$528K | ﹤0.01% | 2693 |
|
|
2024
Q3 | $329K | Buy |
39,308
+30,792
| +362% | +$258K | ﹤0.01% | 3230 |
|
|
2024
Q2 | $58K | Sell |
8,516
-29,688
| -78% | -$202K | ﹤0.01% | 3609 |
|
|
2024
Q1 | $97K | Sell |
38,204
-101,391
| -73% | -$257K | ﹤0.01% | 3655 |
|
|
2023
Q4 | $336K | Buy |
139,595
+26,191
| +23% | +$63K | ﹤0.01% | 3240 |
|
|
2023
Q3 | $385K | Sell |
113,404
-170,003
| -60% | -$577K | ﹤0.01% | 2688 |
|
|
2023
Q2 | $2.08M | Buy |
283,407
+126,386
| +80% | +$929K | ﹤0.01% | 1716 |
|
|
2023
Q1 | $1.63M | Sell |
157,021
-81,394
| -34% | -$843K | ﹤0.01% | 1774 |
|
|
2022
Q4 | $2.82M | Buy |
238,415
+68,225
| +40% | +$806K | ﹤0.01% | 1433 |
|
|
2022
Q3 | $3.57M | Buy |
170,190
+146,857
| +629% | +$3.08M | ﹤0.01% | 1291 |
|
|
2022
Q2 | $724K | Sell |
23,333
-41,222
| -64% | -$1.28M | ﹤0.01% | 2306 |
|
|
2022
Q1 | $2.65M | Buy |
64,555
+684
| +1% | +$28.1K | ﹤0.01% | 1573 |
|
|
2021
Q4 | $2.78M | Buy |
63,871
+17,026
| +36% | +$740K | ﹤0.01% | 1615 |
|
|
2021
Q3 | $2.35M | Buy |
46,845
+2,817
| +6% | +$141K | ﹤0.01% | 1747 |
|
|
2021
Q2 | $2.77M | Sell |
44,028
-8,725
| -17% | -$550K | ﹤0.01% | 1534 |
|
|
2021
Q1 | $4.9M | Buy |
52,753
+11,576
| +28% | +$1.08M | ﹤0.01% | 1205 |
|
|
2020
Q4 | $3.69M | Sell |
41,177
-26,485
| -39% | -$2.37M | ﹤0.01% | 1180 |
|
|
2020
Q3 | $6.99M | Sell |
67,662
-3,857
| -5% | -$399K | ﹤0.01% | 826 |
|
|
2020
Q2 | $5.66M | Sell |
71,519
-56,272
| -44% | -$4.45M | ﹤0.01% | 870 |
|
|
2020
Q1 | $7.39M | Sell |
127,791
-57,468
| -31% | -$3.33M | 0.01% | 729 |
|
|
2019
Q4 | $10M | Buy |
185,259
+128,299
| +225% | +$6.92M | 0.01% | 847 |
|
|
2019
Q3 | $2.98M | Sell |
56,960
-6,338
| -10% | -$331K | ﹤0.01% | 1442 |
|
|
2019
Q2 | $3.06M | Buy |
63,298
+23,201
| +58% | +$1.12M | ﹤0.01% | 1456 |
|
|
2019
Q1 | $2.03M | Buy |
40,097
+13,474
| +51% | +$680K | ﹤0.01% | 1555 |
|
|
2018
Q4 | $1.58M | Sell |
26,623
-19,959
| -43% | -$1.18M | ﹤0.01% | 1503 |
|
|
2018
Q3 | $3.07M | Buy |
46,582
+32,973
| +242% | +$2.17M | ﹤0.01% | 1434 |
|
|
2018
Q2 | $687K | Sell |
13,609
-11,468
| -46% | -$579K | ﹤0.01% | 2082 |
|
|
2018
Q1 | $1.32M | Buy |
25,077
+2,621
| +12% | +$138K | ﹤0.01% | 1613 |
|
|
2017
Q4 | $1.04M | Buy |
22,456
+8,900
| +66% | +$414K | ﹤0.01% | 1621 |
|
|
2017
Q3 | $548K | Sell |
13,556
-7,169
| -35% | -$290K | ﹤0.01% | 1865 |
|
|
2017
Q2 | $702K | Buy |
20,725
+19,465
| +1,545% | +$659K | ﹤0.01% | 1740 |
|
|
2017
Q1 | $37K | Sell |
1,260
-3,676
| -74% | -$108K | ﹤0.01% | 3191 |
|
|
2016
Q4 | $162K | Buy |
4,936
+1,749
| +55% | +$57.4K | ﹤0.01% | 2398 |
|
|
2016
Q3 | $101K | Buy |
3,187
+1,140
| +56% | +$36.1K | ﹤0.01% | 2438 |
|
|
2016
Q2 | $58K | Sell |
2,047
-18,751
| -90% | -$531K | ﹤0.01% | 2529 |
|
|
2016
Q1 | $749K | Buy |
20,798
+20,642
| +13,232% | +$743K | ﹤0.01% | 1529 |
|
|
2015
Q4 | $7K | Sell |
156
-2,958
| -95% | -$133K | ﹤0.01% | 2856 |
|
|
2015
Q3 | $87K | Sell |
3,114
-9,193
| -75% | -$257K | ﹤0.01% | 2413 |
|
|
2015
Q2 | $393K | Buy |
12,307
+11,226
| +1,038% | +$358K | ﹤0.01% | 1850 |
|
|
2015
Q1 | $30K | Sell |
1,081
-982
| -48% | -$27.3K | ﹤0.01% | 2960 |
|
|
2014
Q4 | $56K | Buy |
2,063
+1,035
| +101% | +$28.1K | ﹤0.01% | 2957 |
|
|
2014
Q3 | $21K | Sell |
1,028
-36,568
| -97% | -$747K | ﹤0.01% | 3388 |
|
|
2014
Q2 | $827K | Sell |
37,596
-41,800
| -53% | -$919K | ﹤0.01% | 1790 |
|
|
2014
Q1 | $1.99M | Buy |
79,396
+75,249
| +1,815% | +$1.88M | ﹤0.01% | 1327 |
|
|
2013
Q4 | $90K | Sell |
4,147
-13,649
| -77% | -$296K | ﹤0.01% | 3083 |
|
|
2013
Q3 | $338K | Sell |
17,796
-2,080
| -10% | -$39.5K | ﹤0.01% | 2339 |
|
|
2013
Q2 | $287K | Buy |
+19,876
| New | +$287K | ﹤0.01% | 2516 |
|